Abhijit “Ron” Mazumder, Ph.D.

Abhijit “Ron” Mazumder, Ph.D.

Partner atIllumina VenturesCalifornia

Abhijit “Ron” Mazumder is a partner with nearly 30 years of experience in biomarkers and diagnostics. He previously held roles at Johnson & Johnson, Merck, and Genentech.

What Abhijit can write

Writes checks ofNot reported
Comes in atSeed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. Johnson & Johnson
  2. Merck
  3. Genentech · vice president and global head of Oncology Biomarker Development and Companion Diagnostics
  4. Johnson & Johnson
  5. Merck
  6. Illumina Ventures · Partner
    Now

Investments named in public bios

AttoviaBullseye BiosciencesCubaseBioDELFI DiagnosticsIambic TherapeuticsIntegrated BiosciencesOnckoSerinus BiosciencesSonoThera

Focus

biomarkerstechnologiescomputational approachespharmaceutical diagnosticscompanion diagnosticspharmaceutical

Education

The Johns Hopkins University, bachelor’s degreeUniversity of Maryland, Ph.D.Lehigh University, Master of Business Administration

Also at Illumina Ventures

Partners like Abhijit

At firms with a similar stage, sector and check size.

Alert me when Illumina Ventures is active

One email when Abhijit's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Abhijit “Ron” Mazumder, Ph.D.?

Abhijit “Ron” Mazumder is a partner with nearly 30 years of experience in biomarkers and diagnostics. He previously held roles at Johnson & Johnson, Merck, and Genentech.

How much does Abhijit “Ron” Mazumder, Ph.D. invest?

Illumina Ventures has not reported a check size. It invests at seed, series a.

How do I pitch Abhijit “Ron” Mazumder, Ph.D.?

A warm intro from a founder Illumina Ventures backed works best.

What did Abhijit “Ron” Mazumder, Ph.D. do before Illumina Ventures?

Johnson & Johnson; Merck; vice president and global head of Oncology Biomarker Development and Companion Diagnostics at Genentech; Johnson & Johnson; Merck.

Last updated 2026-10-15. Is this you? Ask for a correction.